BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 467465)

  • 1. Phenytoin binding to human albumin.
    Lecomte M; Zini R; d'Athis P; Tillement JP
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):23-8. PubMed ID: 467465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of free fatty acid concentration on drug binding to plasma albumin.
    Spector AA; Santos EC; Ashbrook JD; Fletcher JE
    Ann N Y Acad Sci; 1973 Nov; 226():247-58. PubMed ID: 4520396
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of enflurane, halothane and the halothane metabolite trifluoroacetic acid with the binding of acidic drugs to human serum albumin. An in vitro study.
    Dale O
    Biochem Pharmacol; 1986 Feb; 35(4):557-61. PubMed ID: 3947389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
    Albengres E; Urien S; Kusmierek J; Tillement JP
    Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of albumin conformation on binding of phenylbutazone and oxyphenbutazone to human serum albumin.
    Abd Elbary A; Vallner JJ; Whitworth CW
    J Pharm Sci; 1982 Feb; 71(2):241-4. PubMed ID: 7062254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in the binding affinity of warfarin and phenprocoumon to human serum albumin in relation to surgery.
    Vorum H; Jørgensen HR; Brodersen R
    Eur J Clin Pharmacol; 1993; 44(2):157-62. PubMed ID: 8453960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids.
    Patel IH; Levy RH
    Epilepsia; 1979 Feb; 20(1):85-90. PubMed ID: 369855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of free fatty acids on binding of drugs by bovine serum albumin, by human serum albumin and by rabbit serum.
    Rudman D; Bixler TJ; Del Rio AE
    J Pharmacol Exp Ther; 1971 Feb; 176(2):261-72. PubMed ID: 4105545
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs.
    Decroix MO; Zini R; Chaumeil JC; Tillement JP
    Biochem Pharmacol; 1988 Jul; 37(14):2807-14. PubMed ID: 3395358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein binding and interaction studies with piroxicam.
    Trnavská Z; Trnavský K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):81-5. PubMed ID: 6493354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepam.
    McNamara PJ; Trueb V; Stoeckel K
    Biochem Pharmacol; 1990 Sep; 40(6):1247-53. PubMed ID: 2403378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
    Perucca E
    Ther Drug Monit; 1980; 2(4):331-44. PubMed ID: 7013166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy.
    Vorum H; Honoré B
    J Pharm Pharmacol; 1996 Aug; 48(8):870-5. PubMed ID: 8887741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A spectroscopic study of the interaction of isoflavones with human serum albumin.
    Mahesha HG; Singh SA; Srinivasan N; Rao AG
    FEBS J; 2006 Feb; 273(3):451-67. PubMed ID: 16420470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of spin labeling to drug assays. II. Determination of the binding of [14C]-phenytoin and spin-labeled phenytoins to albumin and human serum.
    Chou D; Polnaszek CF; Yost Y; Leppik IE; Holtzman JL
    Mol Pharmacol; 1981 Nov; 20(3):674-80. PubMed ID: 7329409
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin.
    Essassi D; Zini R; Tillement JP
    J Pharm Sci; 1990 Jan; 79(1):9-13. PubMed ID: 2313585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.